Organization | Kansas State University

Kansas State University Report issue

Academic/Hospital Phase 4

Founded: Manhattan KS United States (1863)

Organization Overview

First Clinical Trial

2006

NCT00930956

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Kansas State University

Active Ingredients

Drugs in Phase 4 Trials (5)

atovaquone (mepron) (1 trial)

chloroquine (1 trial)

doxycycline (vibramycin) (1 trial)

proguanil (1 trial)

rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (1 trial)

Drugs in Other Trials (6)

beetroot juice (1 trial)

black currant (1 trial)

grape seed extract (1 trial)

resistant starch (4 trials)

sodium phytate (1 trial)

whole wheat allergenic extract (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Rabies (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 11